These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 33374598)

  • 1. Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies.
    Eltokhi A; Santuy A; Merchan-Perez A; Sprengel R
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
    de Bartolomeis A; Latte G; Tomasetti C; Iasevoli F
    Mol Neurobiol; 2014 Feb; 49(1):484-511. PubMed ID: 23999870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSD95: A synaptic protein implicated in schizophrenia or autism?
    Coley AA; Gao WJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():187-194. PubMed ID: 29169997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum.
    Martella G; Meringolo M; Trobiani L; De Jaco A; Pisani A; Bonsi P
    Eur J Neurosci; 2018 Mar; 47(6):701-708. PubMed ID: 28921757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of selected postsynaptic scaffolding proteins at glutamatergic synapses in autism-related animal models.
    Meliskova V; Havranek T; Bacova Z; Bakos J
    J Integr Neurosci; 2021 Dec; 20(4):1047-1057. PubMed ID: 34997728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic neurotransmission in the nucleus tractus solitarii: structural and functional characteristics.
    Baude A; Strube C; Tell F; Kessler JP
    J Chem Neuroanat; 2009 Nov; 38(3):145-53. PubMed ID: 19778680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic dysfunction in schizophrenia.
    Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
    Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
    Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
    Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic abnormalities and cytoplasmic glutamate receptor aggregates in contactin associated protein-like 2/Caspr2 knockout neurons.
    Varea O; Martin-de-Saavedra MD; Kopeikina KJ; Schürmann B; Fleming HJ; Fawcett-Patel JM; Bach A; Jang S; Peles E; Kim E; Penzes P
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6176-81. PubMed ID: 25918374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread alterations in the synaptic proteome of the adolescent cerebral cortex following prenatal immune activation in rats.
    Györffy BA; Gulyássy P; Gellén B; Völgyi K; Madarasi D; Kis V; Ozohanics O; Papp I; Kovács P; Lubec G; Dobolyi Á; Kardos J; Drahos L; Juhász G; Kékesi KA
    Brain Behav Immun; 2016 Aug; 56():289-309. PubMed ID: 27058163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.
    Gao R; Penzes P
    Curr Mol Med; 2015; 15(2):146-67. PubMed ID: 25732149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of glutamate and its receptors in autism spectrum disorder.
    Nisar S; Bhat AA; Masoodi T; Hashem S; Akhtar S; Ali TA; Amjad S; Chawla S; Bagga P; Frenneaux MP; Reddy R; Fakhro K; Haris M
    Mol Psychiatry; 2022 May; 27(5):2380-2392. PubMed ID: 35296811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular abnormalities and synaptic plasticity in seizure disorders of the immature nervous system.
    Swann JW; Hablitz JJ
    Ment Retard Dev Disabil Res Rev; 2000; 6(4):258-67. PubMed ID: 11107191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.
    Nicosia N; Giovenzana M; Misztak P; Mingardi J; Musazzi L
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
    Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
    Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic environment and extrasynaptic glutamate signals: The quest continues.
    Rusakov DA; Stewart MG
    Neuropharmacology; 2021 Sep; 195():108688. PubMed ID: 34174263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.
    Lepeta K; Kaczmarek L
    Schizophr Bull; 2015 Sep; 41(5):1003-9. PubMed ID: 25837304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic elimination by microglia and disturbed higher brain functions.
    Miyanishi K; Sato A; Kihara N; Utsunomiya R; Tanaka J
    Neurochem Int; 2021 Jan; 142():104901. PubMed ID: 33181238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbed proteostasis in autism spectrum disorders.
    Louros SR; Osterweil EK
    J Neurochem; 2016 Dec; 139(6):1081-1092. PubMed ID: 27365114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.